Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

44%

4 of 9 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (5)
Early P 1 (1)
P 1 (2)
P 2 (4)
P 3 (2)

Trial Status

Completed9
Unknown4
Active Not Recruiting2
Not Yet Recruiting2
Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07454915Phase 2RecruitingPrimary

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

NCT07545746Phase 2Not Yet Recruiting

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

NCT04788849CompletedPrimary

Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples

NCT03196180Early Phase 1CompletedPrimary

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

NCT06258564CompletedPrimary

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization

NCT02149030Not ApplicableActive Not RecruitingPrimary

Effectiveness of Cervical Screening in HPV Vaccinated Women

NCT04755517Not ApplicableEnrolling By InvitationPrimary

Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400)

NCT06273553Phase 1Not Yet Recruiting

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

NCT05405270Recruiting

Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment

NCT05851079UnknownPrimary

Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions

NCT03064087Active Not RecruitingPrimary

Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples

NCT04312737CompletedPrimary

Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus

NCT04484415Phase 3UnknownPrimary

Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)

NCT02354534Phase 1CompletedPrimary

Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

NCT01550783Not ApplicableCompleted

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

NCT03274206Phase 2UnknownPrimary

A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)

NCT02067468Not ApplicableCompleted

Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia

NCT03366493Phase 3UnknownPrimary

The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection

NCT00081263Phase 2Completed

Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia

NCT02811367Not ApplicableCompleted

The HPV Self-test as a Test of Cure in Madagascar

Showing all 20 trials

Research Network

Activity Timeline